...
首页> 外文期刊>Current medicinal chemistry >Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) in atherogenesis: a brief review.
【24h】

Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) in atherogenesis: a brief review.

机译:动脉粥样硬化中的凝集素样氧化型低密度脂蛋白受体1(LOX-1):简要综述。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is a scavenger receptor that primarily binds and regulates oxidized low-density lipoprotein (LDL). Expression of LOX-1 is regulated by a feed-forward system stimulated by oxidized LDL (oxLDL), a major component of atherosclerosis. LOX-1 is a homodimer with a reactive backbone that can bind to a host of different ligands, including small molecules, and whole cells. LOX-1 is involved in many intercellular, intracellular, and molecular processes that are atherogenic. LOX-1 levels are elevated within atherosclerotic plaques and its expression is induced by proinflammatory cytokines. The ability of LOX-1 to bind many different ligands and control several atherogenic processes makes this receptor a likely vascular disease biomarker as well as an ideal choice for drug therapy aimed at preventing cardiovascular disease.
机译:凝集素样氧化型低密度脂蛋白受体-1(LOX-1)是一种清道夫受体,主要结合并调节氧化型低密度脂蛋白(LDL)。 LOX-1的表达受前馈系统调节,该系统受动脉粥样硬化的主要成分氧化LDL(oxLDL)的刺激。 LOX-1是具有反应性骨架的同型二聚体,可以与许多不同的配体结合,包括小分子和整个细胞。 LOX-1参与许多动脉粥样硬化的细胞间,细胞内和分子过程。 LOX-1水平在动脉粥样硬化斑块内升高,其表达是由促炎细胞因子诱导的。 LOX-1结合许多不同配体并控制多种动脉粥样硬化过程的能力使该受体成为可能的血管疾病生物标志物,并且是旨在预防心血管疾病的药物治疗的理想选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号